A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
Clinical trial NCT01920061 · COMPLETED
Trial details
- NCT number
- NCT01920061
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-10
- Primary completion
- 2020-01-08
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.